| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Secora Michael is a Chief Financial Officer at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $7.65 | $229,504.50 | -1.0% | +4.6% | -40.8% | |
| Oct 9, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $6.34 | $190,131.00 | -1.0% | +21.8% | -3.9% | |
| Sep 11, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $6.24 | $187,228.50 | -1.1% | +15.7% | -24.8% | |
| Aug 14, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $6.35 | $190,434.00 | -1.1% | +20.7% | -10.2% | |
| Jul 10, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $7.28 | $218,353.50 | -1.1% | -10.9% | -21.0% | |
| Jun 14, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 30,000 | $9.30 | $278,880.00 | -1.2% | -29.8% | -46.9% | |
| Apr 17, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 48,124 | $7.63 | $367,006.79 | -1.9% | +15.1% | -26.4% | |
| Mar 13, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $10.74 | $537,190.00 | -2.0% | -21.9% | -45.9% | |
| Feb 14, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $10.16 | $507,984.99 | -1.4% | -8.0% | -22.2% | |
| Jan 17, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $10.35 | $517,507.50 | -2.5% | -26.2% | -37.6% |